About BONESUPPORT
BONESUPPORT is a company based in Lund (Sweden) founded in 2000. BONESUPPORT has raised $101.08 million across 9 funding rounds from investors including Kreos Capital, European Union and Healthcap. The company has 139 employees as of December 31, 2024. BONESUPPORT offers products and services including CERAMENT BONE VOID FILLER, CERAMENT G, CERAMENT V, and CERAMENT Bead Tray. BONESUPPORT operates in a competitive market with competitors including Kerecis, Kuros Biosciences, OssDsign, Sofregen and Cerapedics, among others.
- Headquarter Lund, Sweden
- Employees 139 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bonesupport Holding Ab
-
Annual Revenue
$81.48 M (USD)52.05as on Dec 31, 2024
-
Net Profit
$12.13 M (USD)-45.41as on Dec 31, 2024
-
EBITDA
$14.3 M (USD)388.89as on Dec 31, 2024
-
Total Equity Funding
$101.08 M (USD)
in 9 rounds
-
Latest Funding Round
Not available
-
Investors
Kreos Capital
& 13 more
-
Employee Count
139
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BONESUPPORT
BONESUPPORT is a publicly listed company on the OMXSTO with ticker symbol BONEX in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BONESUPPORT
BONESUPPORT offers a comprehensive portfolio of products and services, including CERAMENT BONE VOID FILLER, CERAMENT G, CERAMENT V, and CERAMENT Bead Tray.
Injectable material for treating bone voids from trauma.
Drug-eluting bioceramic for infection-related bone defects.
Bioceramic filler for various bone healing applications.
Tool for delivering bioceramic beads in surgeries.
People of BONESUPPORT
Unlock access to complete
Unlock access to complete
Funding Insights of BONESUPPORT
BONESUPPORT has successfully raised a total of $101.08M across 9 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BONESUPPORT
BONESUPPORT has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include Kreos Capital, European Union and Healthcap.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Investments in deep-tech, life sciences, and transformative tech are managed.
|
Locked | Locked | Locked | |
|
Life science companies are funded through venture capital investments.
|
Locked | Locked | Locked |
Investor details for BONESUPPORT
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BONESUPPORT
Investment portfolio details for BONESUPPORT
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BONESUPPORT
Detailed financials for BONESUPPORT
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bonesupport Comparisons
Peer comparison for BONESUPPORT
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BONESUPPORT
BONESUPPORT operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kerecis, Kuros Biosciences, OssDsign, Sofregen and Cerapedics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Fish-skin acellular dermal matrix technology is provided for wound treatments.
|
|
| Locked | Locked | Locked |
Provider of smart solutions for bone disease management
|
|
| Locked | Locked | Locked |
Developer of regenerative 3D-printed orthopedic implants for craniofacial bone defects and trauma
|
|
| Locked | Locked | Locked |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| Locked | Locked | Locked |
Osteobiologic products are developed using synthetic peptide technology.
|
|
| Locked | Locked | Locked |
Scaffolds for natural repair of 3D soft tissues are developed.
|
Detailed competitors of BONESUPPORT
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bonesupport
Complete news archive for BONESUPPORT
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BONESUPPORT
BONESUPPORT was founded in 2000 and raised its 1st funding round 6 years after it was founded.
BONESUPPORT is headquartered in Lund, Sweden.
Emil Billback is the current CEO of BONESUPPORT.
BONESUPPORT is a funded company, having raised a total of $101.08M across 9 funding rounds to date.
As of Dec 31, 2024, the latest employee count at BONESUPPORT is 139.
Annual revenue of BONESUPPORT is $81.48M as on Dec 31, 2024.
Bonesupport is a Swedish medical technology company dedicated to the development injectable osteoconductive biomaterials for the treatment of fractures caused by osteoporosis, and bone voids or gaps in bone caused by trauma, disease or related to surgical procedures. Its product CERAMENT manufactured using Calcium Sulphate and Hydroxyapatite combined with liquid Iohexol, with its unique properties, is a biphasic injectable ceramic bone substitute intended for bone voids that mimics the properties of cancellous bone and is replaced by bone during the healing process.
BONESUPPORT's top competitors include Kerecis, OssDsign and Kuros Biosciences.
BONESUPPORT offers CERAMENT BONE VOID FILLER, CERAMENT G, CERAMENT V, and CERAMENT Bead Tray.
Yes, BONESUPPORT is publicly traded on OMXSTO under the ticker symbol BONEX.
BONESUPPORT has 14 investors. Key investors include Kreos Capital, European Union, Healthcap, Industrifonden, and AP3.
The ticker symbol of BONESUPPORT is BONEX on OMXSTO.